Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Total Non-Current Liabilities: 2013-2019

Historic Total Non-Current Liabilities for Soleno Therapeutics (SLNO) over the last 5 years, with Sep 2019 value amounting to $7.8 million.

  • Soleno Therapeutics' Total Non-Current Liabilities fell 29.06% to $7.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $7.8 million, marking a year-over-year decrease of 29.06%. This contributed to the annual value of $7.1 million for FY2018, which is 0.48% down from last year.
  • Per Soleno Therapeutics' latest filing, its Total Non-Current Liabilities stood at $7.8 million for Q3 2019, which was down 45.46% from $14.3 million recorded in Q2 2019.
  • In the past 5 years, Soleno Therapeutics' Total Non-Current Liabilities registered a high of $20.3 million during Q1 2015, and its lowest value of $2.0 million during Q3 2017.
  • In the last 3 years, Soleno Therapeutics' Total Non-Current Liabilities had a median value of $7.8 million in 2019 and averaged $8.4 million.
  • Per our database at Business Quant, Soleno Therapeutics' Total Non-Current Liabilities slumped by 93.78% in 2015 and then soared by 512.26% in 2018.
  • Quarterly analysis of 5 years shows Soleno Therapeutics' Total Non-Current Liabilities stood at $4.9 million in 2015, then crashed by 57.52% to $2.1 million in 2016, then surged by 244.45% to $7.1 million in 2017, then declined by 0.48% to $7.1 million in 2018, then decreased by 29.06% to $7.8 million in 2019.
  • Its last three reported values are $7.8 million in Q3 2019, $14.3 million for Q2 2019, and $9.4 million during Q1 2019.